Metenolone acetate
 | |
| Clinical data | |
|---|---|
| Trade names | Primobolan, Primobolan S, Primonabol, Nibal |
| Routes of administration | Oral |
| Identifiers | |
| |
| Synonyms | NSC-74226; SH-567; SQ-16496 |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C22H32O3 |
| Molar mass | 344.50 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Metenolone acetate (INN), or methenolone acetate (USAN, BANM) (brand names Primobolan, Primobolan S, Primonabol, Nibal), also known as 1-methyl-4,5α-dihydro-δ1-testosterone 17β-acetate (1-methyl-δ1-DHT 17β-acetate) or 1-methylandrost-1,4-dien-17β-ol-3-one 17β-acetate, is a synthetic, orally active anabolic-androgenic steroid (AAS) and derivative of dihydrotestosterone (DHT) that is marketed in Europe, Australia, and Mexico.[1][2][3] It has been used in the treatment of bone marrow diseases and anemia.[3] Metenolone acetate is the C17β acetate ester and a prodrug of metenolone,[1][2] and is the form of metenolone that is used orally; the form that is used via depot intramuscular injection is metenolone enanthate.[2] Along with mesterolone, metenolone acetate is one of the few AAS that is orally active but is not 17α-alkylated.[4]
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 784–. ISBN 978-1-4757-2085-3.
- 1 2 3 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 660–661. ISBN 978-3-88763-075-1.
- 1 2 I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 178–. ISBN 978-94-011-4439-1.
- ↑ Kicman AT (June 2008). "Pharmacology of anabolic steroids". British Journal of Pharmacology. 154 (3): 502–21. PMC 2439524
. PMID 18500378. doi:10.1038/bjp.2008.165.